S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
Log in
NASDAQ:STOK

Stoke Therapeutics Earnings Date, Estimates & History

$54.01
-2.88 (-5.06 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$50.49
Now: $54.01
$57.89
50-Day Range
$56.89
MA: $62.48
$69.81
52-Week Range
$15.82
Now: $54.01
$71.58
Volume173,302 shs
Average Volume137,870 shs
Market Capitalization$1.81 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.63

Earnings

Stoke Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 22nd, 2021 based off prior year's report dates.

Stoke Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Stoke Therapeutics (NASDAQ:STOK) Earnings Estimates

2021 EPS Consensus Estimate: ($1.57)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211($0.37)($0.37)($0.37)
Q2 20211($0.39)($0.39)($0.39)
Q3 20211($0.40)($0.40)($0.40)
Q4 20211($0.41)($0.41)($0.41)

Stoke Therapeutics (NASDAQ STOK) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/22/2021
(Estimated)
       
11/12/20209/30/2020($0.41)($0.41)($0.41)N/A
8/10/20206/30/2020($0.35)($0.39)($0.39)N/A
5/15/20203/31/2020($0.36)($0.34)($0.34)N/A
3/23/202012/31/2019($0.30)($0.09)N/A
11/12/2019Q3($0.2730)($0.26)($0.26)N/A
8/14/2019Q2 2019($0.9570)($1.54)($1.54)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.